Consolidated Financial Results for the Six Months Ended September 30, 2025 [Japanese GAAP]
November 5, 2025
Company name: ARAKAWA CHEMICAL INDUSTRIES, LTD.
Stock exchange listing: Tokyo Stock Exchange
Code number: 4968
URL: https://www.arakawachem.co.jp/en/
Representative: Nobuyuki Takagi, Representative Director and President Contact: Toru Nobuhiro, Managing Director and Executive Officer Phone: +81-6-6209-8500
Scheduled date of filing semi-annual securities report: November 12, 2025 Scheduled date of commencing dividend payments: December 1, 2025 Availability of supplementary explanatory materials on financial results: Available
Schedule of financial results briefing session: Scheduled (for institutional investors/securities analysts)
(Amounts of less than one million yen are rounded down.)
-
Consolidated Financial Results for the Six Months Ended September 30, 2025 (April 1, 2025 - September 30,
2025)
Consolidated Operating Results (% indicates changes from the previous corresponding period.)
Net sales
Operating profit
Ordinary profit
Profit attributable to owners of parent
Six months ended
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
September 30, 2025
40,367
2.6
929
196.0
639
103.8
724
(55.7)
September 30, 2024
39,327
13.4
313
-
313
-
1,634
-
(Note) Comprehensive income: Six months ended September 30, 2025: ¥ (49) million [-%]
Six months ended September 30, 2024: ¥ 2,181 million [321.9%]
Basic earnings per share
Diluted earnings per share
Six months ended
Yen
Yen
September 30, 2025
36.53
-
September 30, 2024
82.41
-
Consolidated Financial Position
Total assets
Net assets
Equity ratio
Millions of yen
Millions of yen
%
As of September 30, 2025
121,261
56,692
48.3
As of March 31, 2025
122,297
57,237
47.8
(Reference) Equity: As of September 30, 2025: ¥ 58,567 million
As of March 31, 2025: ¥ 58,475 million
-
Dividends
Annual dividends
1st quarter-end
2nd quarter-end
3rd quarter-end
Year-end
Total
Yen
Yen
Yen
Yen
Yen
Fiscal year ended
March 31, 2025
-
24.00
-
25.00
49.00
Fiscal year ending March 31, 2026
-
25.00
Fiscal year ending March 31, 2026
(Forecast)
-
25.00
50.00
(Note) Revision to the forecast for dividends announced most recently: None
- Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2026 (April 1, 2025 - March 31,
(% indicates changes from the previous corresponding period.)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Full year | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen |
85,000 | 5.9 | 2,800 | 164.7 | 2,400 | 180,7 | 1,800 | (31.9) | 90.73 | |
(Note) Revision to the financial results forecast announced most recently: None
* Notes:Significant changes in the scope of consolidation during the period under review: None
Newly included: - companies (Company name) Excluded: - companies (Company name)
Adoption of accounting treatment specific to the preparation of semi-annual consolidated financial statements: None
Changes in accounting policies, changes in accounting estimates and retrospective restatement
Changes in accounting policies due to the revision of accounting standards: None
Changes in accounting policies other than 1) above: None
Changes in accounting estimates: None
Retrospective restatement: None
Total number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares): September 30, 2025: 20,652,400 shares
March 31, 2025: 20,652,400 shares
Total number of treasury shares at the end of the period: September 30, 2025: 813,671 shares
March 31, 2025: 813,611 shares
Average number of shares during the period:
Six months ended September 30, 2025: 19,838,774 shares
Six months ended September 30, 2024: 19,838,789 shares
These semi-annual consolidated financial results are outside the scope of review by certified public accountants or an audit firm.
Explanation on the proper use of financial results forecast and other special notes
Forward-looking statements, including financial results forecasts, contained in this document are based on information currently available to the Company and certain assumptions deemed reasonable. Therefore, these statements do not constitute a guarantee that they will be realized. Actual results may differ materially from these statements due to various factors.
Qualitative Information on Semi-annual Financial Results
Explanation of Operating Results
During the six months ended September 30, 2025, the Japanese economy continued its modest recovery, supported by improvements in employment and income situation. However, the global economy remains uncertain, with some regions experiencing stagnation, and risks such as US trade policies, China's economic slowdown, increasing geopolitical risks, among others, creating continued uncertainty about prospects.
In this environment, ARAKAWA CHEMICAL INDUSTRIES, LTD. and its subsidiaries (the "Group") have been pressing forward with key initiatives under "V-ACTION for Sustainability," the 5th Medium-Term Management Plan, now in its final year. In the area of photo-curable resins and fine chemical products-positioned under the "NOBASU" mission-capacity expansions have been completed, and we are steadily progressing toward mass production in response to growing market demand. We are also working to develop new businesses in the life sciences field (healthcare, agriculture, and cosmetics) by leveraging natural materials such as pine and microalgae, with the aim of commercialization. As for hydrogenated hydrocarbon resin, we recognize the stable
operation of Chiba Arkon Production Limited as an important company-wide challenge, and we have improved its operation rate by strengthening our organizational structure to address this issue, with the "Arkon Special Committee" playing a central role.
In terms of operating results, sales of photo-curable resins for functional coating chemicals increased,
surpassing the previous year's period due to the recovery in smartphone shipments, and sales of fine chemicals
products and polishing agents for hard disk substrates have been maintained record-high levels.
As a result, for the six months ended September 30, 2025, the Group posted net sales of 40,367 million (up 2.6% year on year), operating profit of 929 million (up 196.0% year on year), ordinary profit of 639 million (up 103.8% year on year), and profit attributable to owners of parent of 724 million (down 55.7% year on year).
Operating results by segment are as follows. Net sales for each segment do not include inter-segment net sales.
Functional Coating Chemicals Business
The electrical and precision equipment related industries are experiencing steady demand, especially for electronic components. In this environment, demand recovery in smartphones and displays led to increased sales of photo-curable resins. Furthermore, thermosetting resins, positioned under the "SODATERU" mission, also saw increased sales through new adoption and expanded sales channels.
As a result, net sales were ¥8,977 million (up 9.3% year on year), and segment income was ¥1,008 million (up
68.4% year on year).
Paper Chemicals & Environmental Business
Regarding the paper manufacturing industry, paper and paperboard production has continued to fall below the previous year's levels in Japan. In China, amid sluggish demand, production continued to increase, which affected market conditions in other Asian regions and created a challenging situation. Under these conditions, overseas price competition for paper strengthening agents has intensified and resulted in a decline in profits.
As a result, net sales were 10,094 million (down 8.2% year on year), and segment income was 534 million (down 47.2% year on year).
Adhesive & Biomass Materials Business
In the adhesives industry, concerns exist that demand may decline in the automobile-related field due to the uncertainty surrounding U.S. tariff policies, resulting in weak demand for those used for tapes and sheets, etc. In this environment, sales of rosin tackifier for adhesives remained stable, particularly in the Asian region. Regarding hydrogenated hydrocarbon resins, Chiba Arkon Production Limited improved its operation rate and has begun stable supply to Europe.
As a result, net sales were 13,890 million (up 5.0% year on year), and segment loss was 603 million (segment loss of 1,292 million in the same period of the previous year).
Fine Chemicals & Electronics Business
In the electronics industry, demand for electronic components, etc., is recovering, and investment in data centers, associated with increased demand for generative AI, is growing steadily. In this environment, sales of polishing agents for hard disk substrates used in data centers and fine chemical products for semiconductor-related advanced materials increased. Regarding polishing agents and compounded products for electronic material, we are progressively implementing price revisions, but cost increases are currently outpacing sales prices. Regarding newly enhanced production capacity for semiconductor-related advanced materials, depreciation has been recorded since May 2025, and mass production is scheduled to begin in the latter half of the next fiscal year after obtaining customer approvals.
As a result, net sales were ¥7,366 million (up 7.6% year on year), and segment income was ¥274 million (down
25.4% year on year).
Explanation of Financial Position
Overview of Assets and Liabilities
Total assets as of September 30, 2025, decreased by ¥1,036 million compared to the end of the previous consolidated fiscal year, totaling ¥121,261 million. The main reasons include a decrease of ¥889 million in inventories and a decrease of ¥1,192 million in property, plant and equipment, despite an increase of 1,301 million in investment securities.
Liabilities decreased by ¥491 million compared to the end of the previous consolidated fiscal year, reaching
¥64,568 million. This was despite a 2,163 million increase in short-term borrowings, mainly attributable to decreases in notes and accounts payable-trade of ¥1,280 million and long-term borrowings of ¥1,406 million.
Total net assets decreased by ¥545 million compared to the end of the previous consolidated fiscal year to
¥56,692 million, mainly due to decreases in foreign currency translation adjustment, despite increases in
retained earnings and valuation difference on available-for-sale securities.
Overview of Cash Flows
Cash and cash equivalents at the end of the period under review increased by 932 million from the end of the previous fiscal year to 7,367 million.
Net cash provided by operating activities increased by ¥1,249 million. This was due to net income before income taxes (¥667 million) and depreciation (¥2,710 million), among other factors.
Net cash used in investing activities decreased by ¥622 million. This resulted from a decrease in cash mainly due to the purchase of property, plant and equipment and intangible assets (¥1,904 million), among other factors, despite an increase in cash from the decrease in time deposits (¥1,302 million).
Net cash provided by financing activities increased by ¥324 million. This was due to an increase in cash resulting from a net increase in borrowings (826 million), among other factors, despite a decrease in cash due to dividend payments (¥495 million), among other factors.
Forward-looking Statements such as Earnings Forecasts
There are no revisions to the full-year consolidated earnings forecast disclosed on May 14, 2025. (Reference) Depreciation recognized at Chiba Arkon Production Limited
(Millions of yen)
FY 2022
FY 2023
FY 2024
FY 2025 (forecast)
FY 2026 (forecast)
1,043
2,315
1,954
Approx. 1,600
Approx. 1,400
The forward-looking statements regarding performance forecasts and other future projections contained in this document are based on the information currently available to our company and on certain assumptions deemed reasonable. However, these statements are not promises or guarantees of future performance by the company.
Actual results may differ significantly due to various factors.
Semi-annual Consolidated Financial Statements and Principal Notes
Semi-annual Consolidated Balance Sheets
(Millions of yen)
As of March 31, 2025 As of September 30, 2025
Assets
Current assets
Cash and deposits
9,431
9,074
Notes and accounts receivable - trade
25,884
25,778
Electronically recorded monetary claims -
operating
2,258
2,241
Merchandise and finished goods
12,619
11,798
Work in process
1,468
1,439
Raw materials and supplies
9,730
9,692
Other
997
1,432
Allowance for doubtful accounts
(126)
(115)
Total current assets
62,264
61,341
Non-current assets
Property, plant and equipment
Buildings and structures, net
18,604
18,134
Machinery, equipment and vehicles, net
13,487
12,303
Land
5,008
5,003
Construction in progress
846
1,346
Other, net
1,092
1,059
Total property, plant and equipment
39,039
37,847
Intangible assets
1,374
1,180
Investments and other assets
Investment securities
10,105
11,407
Retirement benefit asset
7,392
7,585
Deferred tax assets
288
237
Other
386
409
Allowance for doubtful accounts
(86)
(80)
Total investments and other assets
18,086
19,559
Total non-current assets
58,500
58,587
Deferred assets
Business commencement expenses
1,532
1,331
Total deferred assets
1,532
1,331
Total assets
122,297
121,261
Liabilities
Current liabilities
Notes and accounts payable - trade
9,200
7,920
Electronically recorded obligations - operating
1,172
1,057
Short-term borrowings
18,319
20,482
Income taxes payable
774
370
Accrued consumption taxes
52
238
Provision for bonuses
1,370
1,246
Provision for bonuses for directors (and other
officers)
27
10
Provision for repairs
820
525
Provision for loss on business liquidation
56
57
Asset retirement obligations
26
-
Notes payable - facilities
104
132
Other
5,682
5,910
Total current liabilities
37,608
37,953
Non-current liabilities
Bonds payable
10,000
10,000
Long-term borrowings
11,061
9,654
Deferred tax liabilities
4,161
4,742
Retirement benefit liability
259
270
Asset retirement obligations
1,832
1,829
Other
135
117
Total non-current liabilities
27,451
26,615
Total liabilities
65,060
64,568
Net assets
Shareholders' equity
Share capital
3,343
3,343
Capital surplus
3,564
3,564
Retained earnings
40,619
40,848
Treasury shares
(1,211)
(1,211)
Total shareholders' equity
46,315
46,544
Accumulated other comprehensive income
Valuation difference on available-for-sale
securities
4,384
5,291
Foreign currency translation adjustment
4,671
3,819
Remeasurements of defined benefit plans
3,103
2,911
Total accumulated other comprehensive income
12,159
12,022
Non-controlling interests
(1,237)
(1,874)
Total net assets
57,237
56,692
Total liabilities and net assets
122,297
121,261
(Millions of yen) As of March 31, 2025 As of September 30, 2025
Semi-annual Consolidated Statements of Income and Comprehensive Income Semi-annual Consolidated Statements of Income
(Millions of yen)
For the six months ended September 30, 2024
For the six months ended September 30, 2025
Net sales
39,327
40,367
Cost of sales
31,568
31,855
Gross profit
7,759
8,511
Selling, general and administrative expenses
7,445
7,582
Operating profit (loss)
313
929
Non-operating income
Interest income
55
49
Dividend income
114
146
Rental income from real estate
27
28
Foreign exchange gains
137
-
Other
91
125
Total non-operating income
427
350
Non-operating expenses
Interest expenses
189
236
Foreign exchange losses
-
153
Amortization of business commencement expenses
198
198
Other
39
51
Total non-operating expenses
427
640
Ordinary profit (loss)
313
639
Extraordinary income
Gain on sale of non-current assets
984
0
Gain on sale of investment securities
314
121
Total extraordinary income
1,299
121
Extraordinary losses
Loss on sale and retirement of non-current assets
45
93
Total extraordinary losses
45
93
Profit (loss) before income taxes
1,566
667
Income taxes - current
673
374
Income taxes - deferred
156
301
Total income taxes
830
675
Profit (loss)
736
(8)
Profit (loss) attributable to non-controlling interests
(898)
(732)
Profit (loss) attributable to owners of parent
1,634
724
Semi-annual Consolidated Statements of Comprehensive Income
(Millions of yen)
For the six months ended September 30, 2024
For the six months ended September 30, 2025
Profit (loss)
736
(8)
Other comprehensive income
Valuation difference on available-for-sale securities
(101)
907
Foreign currency translation adjustment
1,706
(754)
Remeasurements of defined benefit plans, net of tax
(160)
(193)
Total other comprehensive income
1,444
(40)
Comprehensive income
2,181
(49)
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,914
587
Comprehensive income attributable to non-controlling
interests
(732)
(637)
Semi-annual Consolidated Statements of Cash Flows
(Millions of yen)
For the six months ended
For the six months ended
September 30, 2024
September 30, 2025
Cash flows from operating activities
Profit (loss) before income taxes
1,566
667
Depreciation
2,709
2,710
Amortization of business commencement expenses
198
198
Increase (decrease) in allowance for doubtful accounts
2
(9)
Increase (decrease) in provision for bonuses
(25)
(115)
Increase (decrease) in provision for bonuses for directors (and other officers)
10
(17)
Increase (decrease) in retirement benefit liability
(0)
10
Decrease (increase) in retirement benefit asset
(167)
(189)
Increase (decrease) in provision for loss on business liquidation
(40)
-
Loss (gain) on sale and retirement of non-current assets
(938)
93
Loss (gain) on sale of investment securities
(314)
(121)
Interest and dividend income
(170)
(196)
Interest expenses
189
236
Decrease (increase) in trade receivables
1,615
(262)
Decrease (increase) in inventories
1,715
677
Increase (decrease) in trade payables
(1,884)
(1,241)
Increase (decrease) in accrued consumption taxes
307
320
Other, net
(939)
(707)
Subtotal
3,833
2,055
Interest and dividends received
176
200
Interest paid
(177)
(215)
Income taxes refund (paid)
(434)
(790)
Net cash provided by (used in) operating activities
3,398
1,249
Cash flows from investing activities
Decrease (increase) in time deposits
393
1,302
Purchase of property, plant and equipment
(1,806)
(1,886)
Proceeds from sale of property, plant and equipment
769
0
Purchase of investment securities
(19)
(21)
Proceeds from sale of investment securities
355
155
Purchase of intangible assets
(58)
(18)
Decrease (increase) in investments and other assets
(8)
(26)
Other, net
(34)
(128)
Net cash provided by (used in) investing activities
(407)
(622)
(Millions of yen)
For the six months ended
For the six months ended
September 30, 2024
September 30, 2025
Cash flows from financing activities
Net increase (decrease) in short-term borrowings
(1,126)
2,231
Repayments of long-term borrowings
(1,652)
(1,405)
Purchase of treasury shares
-
(0)
Dividends paid
(476)
(495)
Other, net
(8)
(6)
Net cash provided by (used in) financing activities
(3,264)
324
Effect of exchange rate change on cash and cash equivalents
361
(19)
Net increase (decrease) in cash and cash equivalents
88
932
Cash and cash equivalents at beginning of period
9,164
6,434
Cash and cash equivalents at end of period
9,253
7,367
Notes to Semi-annual Consolidated Financial Statements
(Segment information, etc.) [Segment information]
For the six months ended September 30, 2024 (from April 1, 2024 to September 30, 2024)
Information on net sales and income or loss by reportable segment
(Millions of yen)
Reportable segments
Others (Note)
Total
Functional Coating Chemicals
Paper Chemicals & Environmental
Business
Adhesive & Biomass Materials
Fine Chemicals & Electronics
Total
Net sales
Net sales to external customers
8,211
10,993
13,230
6,843
39,280
47
39,327
Inter-segment sales or transfers
-
-
-
-
-
14
14
Total
8,211
10,993
13,230
6,843
39,280
62
39,342
Segment income (loss)
599
1,011
(1,292)
367
685
28
714
Note: The "Others" category comprises business segments not included in reportable segments, such as non-life insurance business and real estate management.
Reconciliation of total income or loss of reportable segments with the amount reported in the semi-annual consolidated statements of income and main components of the difference (matters related to adjustments)
(Millions of yen)
Income
Amount
Total of reportable segments
685
Income in "Others" category
28
Variance from the allocation of corporate expenses (Note 1)
(4)
Corporate research and development expenses (Note 2)
(188)
Non-operating income and expenses (Note 3)
(207)
Operating loss in the semi-annual consolidated statements of income
313
Notes: 1. The variance from the allocation of corporate expenses primarily represents the difference in the estimated allocation of general and administrative expenses to reportable segments.
Corporate research and development expenses represent new research and development costs not allocated to reportable segments, which are the source of medium- to long-term growth.
Non-operating income and expenses primarily consist of items recorded as non-operating income and expenses in reportable segments.
Information on impairment losses on non-current assets or goodwill, etc., by reportable segment Not applicable
For the six months ended September 30, 2025 (from April 1, 2025 to September 30, 2025)
Information on net sales and income or loss by reportable segment
(Millions of yen)
Reportable segments
Others (Note)
Total
Functional Coating Chemicals
Paper Chemicals & Environmental Business
Adhesive & Biomass Materials
Fine Chemicals & Electronics
Total
Net sales
Net sales to external customers
8,977
10,094
13,890
7,366
40,330
37
40,367
Inter-segment sales or transfers
-
-
-
-
-
21
21
Total
8,977
10,094
13,890
7,366
40,330
58
40,389
Segment income (loss)
1,008
534
(603)
274
1,213
16
1,230
Note: The "Others" category comprises business segments not included in reportable segments, such as non-life insurance business and real estate management.
Reconciliation of total income or loss of reportable segments with the amount reported in the semi-annual consolidated statements of income and main components of the difference (matters related to adjustments)
(Millions of yen)
Income
Amount
Total of reportable segments
1,213
Income in "Others" category
16
Variance from the allocation of corporate expenses (Note 1)
(45)
Corporate research and development expenses (Note 2)
(247)
Non-operating income and expenses (Note 3)
(9)
Operating profit in the semi-annual consolidated statements of income
929
Notes: 1. The variance from the allocation of corporate expenses primarily represents the difference in the estimated allocation of general and administrative expenses to reportable segments.
Corporate research and development expenses represent new research and development costs and new business development costs not allocated to reportable segments, which are the source of medium- to long-term growth.
Non-operating income and expenses primarily consist of items recorded as non-operating income and expenses in reportable segments.
Information on impairment losses on non-current assets or goodwill, etc., by reportable segment Not applicable
(Revenue recognition)
Disaggregation of revenue from contracts with customers
For the six months ended September 30, 2024 (from April 1, 2024 to September 30, 2024)
(Millions of yen)
Reportable segments | Others (Note) | Total | |||||
Functional Coating Chemicals | Paper Chemicals & Environmental Business | Adhesive & Biomass Materials | Fine Chemicals & Electronics | Total | |||
Net sales | |||||||
Japan | 6,623 | 6,012 | 5,449 | 4,341 | 22,426 | 47 | 22,474 |
China | 983 | 1,972 | 3,751 | 1,114 | 7,820 | - | 7,820 |
Asia (excluding China) | 551 | 2,998 | 2,109 | 1,289 | 6,948 | - | 6,948 |
South and North America, Europe, Others | 53 | 11 | 1,921 | 98 | 2,084 | - | 2,084 |
Revenue from contracts with customers | 8,211 | 10,993 | 13,230 | 6,843 | 39,280 | 47 | 39,327 |
Net sales to external customers | 8,211 | 10,993 | 13,230 | 6,843 | 39,280 | 47 | 39,327 |
Note: The "Others" category comprises business segments not included in reportable segments, such as non-life insurance business and real estate management.
For the six months ended September 30, 2025 (from April 1, 2025 to September 30, 2025)
(Millions of yen)
Reportable segments | Others (Note) | Total | |||||
Functional Coating Chemicals | Paper Chemicals & Environmental Business | Adhesive & Biomass Materials | Fine Chemicals & Electronics | Total | |||
Net sales | |||||||
Japan | 7,137 | 5,733 | 5,627 | 4,967 | 23,465 | 37 | 23,502 |
China | 1,163 | 1,610 | 4,499 | 1,110 | 8,384 | - | 8,384 |
Asia (excluding China) | 640 | 2,747 | 1,954 | 1,234 | 6,577 | - | 6,577 |
South and North America, Europe, Others | 36 | 3 | 1,809 | 54 | 1,903 | - | 1,903 |
Revenue from contracts with customers | 8,977 | 10,094 | 13,890 | 7,366 | 40,330 | 37 | 40,367 |
Net sales to external customers | 8,977 | 10,094 | 13,890 | 7,366 | 40,330 | 37 | 40,367 |
Note: The "Others" category comprises business segments not included in reportable segments, such as non-life insurance business and real estate management.
